Conard, J., Lecompte, T., Horellou, M.H., et al. (1981) Antithrombin III in Patients Treated with Subcutaneous or Intravenous Heparin. Thrombosis Research, 22, 507-511.
https://doi.org/10.1016/0049-3848(81)90113-4

has been cited by the following article:

• TITLE: Delayed Onset Low Molecular Weight Heparin Induced Skin Necrosis on a Hemodialysis Patient

  AUTHORS: Suzanne J. Sanchez, Ruben A. Maguad, Grecia P. Darunday

  KEYWORDS: Heparin, Skin Necrosis, Hemodialysis

  JOURNAL NAME: Open Journal of Nephrology, Vol.13 No.2, June 1, 2023

  ABSTRACT: Delayed onset low molecular weight heparin induced skin necrosis is a rare adverse event. It usually occurs at the site of injection, and typically develops within 2 weeks of starting therapy. However, in our case, we presented a 62-year-old woman who is on Hemodialysis twice a week. Her hemodialysis prescription included Enoxaparine 0.2 cc IV as anticoagulant. On her third month of regular hemodialysis, she developed skin necrosis on her right leg and left hand. The diagnosis was made clinically and by exclusion of other possible causes of skin necrosis in a chronic kidney disease patient, such as calciphylaxis. The most important aspect of management, in this case, is early recognition and withdrawal of its use, which were done in our patient.